Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Lam Research
LRCX
|
$792M |
| 2 |
Johnson & Johnson
JNJ
|
$659M |
| 3 |
Datadog
DDOG
|
$571M |
| 4 |
Amazon
AMZN
|
$474M |
| 5 |
Broadcom
AVGO
|
$458M |
Top Sells
| 1 |
Workday
WDAY
|
$1.23B |
| 2 |
AbbVie
ABBV
|
$1.03B |
| 3 |
Advanced Micro Devices
AMD
|
$686M |
| 4 |
Honeywell
HON
|
$673M |
| 5 |
Amgen
AMGN
|
$620M |
Sector Composition
| 1 | Technology | 34.72% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.22% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Brady Corp
BRC
$3.86B
| $47.3M | 0.02% |
640,426
-6,659
| -1% | -$492K |
|
402
Macerich
MAC
$4.74B
| $45.4M | 0.02% |
2,276,219
-674,005
| -23% | -$13.4M |
|
403
Driven Brands
DRVN
$3.11B
| $44.7M | 0.02% |
2,770,158
-394,628
| -12% | -$6.37M |
|
404
NewAmsterdam Pharma
NAMS
$3.04B
| $44.7M | 0.02% |
1,736,777
+196,048
| +13% | +$5.04M |
|
405
Ball Corp
BALL
$13.9B
| $44.6M | 0.02% |
808,162
+100,883
| +14% | +$5.56M |
|
406
Pinduoduo
PDD
$177B
| $44.2M | 0.02% |
455,266
+355,712
| +357% | +$34.5M |
|
407
Citigroup
C
$176B
| $44.1M | 0.02% |
626,815
-326,094
| -34% | -$23M |
|
408
Entegris
ENTG
$12.4B
| $43.8M | 0.02% |
442,065
+9,676
| +2% | +$959K |
|
409
Lincoln Electric
LECO
$13.5B
| $43.5M | 0.02% |
232,013
+32,993
| +17% | +$6.18M |
|
410
Novo Nordisk
NVO
$245B
| $42.7M | 0.02% |
496,088
-396,339
| -44% | -$34.1M |
|
411
Westlake Corp
WLK
$11.5B
| $42.7M | 0.02% |
372,196
+170,791
| +85% | +$19.6M |
|
412
CG Oncology
CGON
$2.52B
| $42.6M | 0.02% |
1,485,843
-40,691
| -3% | -$1.17M |
|
413
Ametek
AME
$43.3B
| $42.2M | 0.02% |
234,059
-30,854
| -12% | -$5.56M |
|
414
Nordson
NDSN
$12.6B
| $42M | 0.02% |
200,953
+2,715
| +1% | +$568K |
|
415
CRA International
CRAI
$1.28B
| $41.7M | 0.02% |
222,570
+24,648
| +12% | +$4.61M |
|
416
Sanofi
SNY
$113B
| $41.6M | 0.02% |
862,520
-19,162
| -2% | -$924K |
|
417
Thor Industries
THO
$5.94B
| $41.5M | 0.02% |
433,768
+4,410
| +1% | +$422K |
|
418
Graphic Packaging
GPK
$6.38B
| $41.1M | 0.02% |
1,513,470
-184,042
| -11% | -$5M |
|
|
CRGX
419
DELISTED
CARGO Therapeutics
CRGX
| $40.9M | 0.02% |
2,830,544
+155,259
| +6% | +$2.24M |
|
420
Waste Connections
WCN
$46.1B
| $40.9M | 0.02% |
238,081
-1,330
| -0.6% | -$228K |
|
421
Ibotta
IBTA
$781M
| $40.8M | 0.02% |
626,905
+154,815
| +33% | +$10.1M |
|
422
DexCom
DXCM
$31.6B
| $40.6M | 0.02% |
521,812
-34,369
| -6% | -$2.67M |
|
423
OneMain Financial
OMF
$7.31B
| $40.5M | 0.02% |
776,649
+3,785
| +0.5% | +$197K |
|
424
Columbia Banking Systems
COLB
$8.05B
| $40.4M | 0.02% |
1,496,646
-766,786
| -34% | -$20.7M |
|
425
Toll Brothers
TOL
$14.2B
| $40.3M | 0.02% |
320,329
+17,682
| +6% | +$2.23M |
|